To avoid a tug-of-war between scientific rigor and operational efficiency, we must prioritize the user and data journeys of sites, patients, and sponsors. Simpler everyday experiences and connected data are the basis for delivering the trials we need rather than what the technology allows.
With your support, ACRP is on an historic path of progress for advocating for the clinical research profession and in service to our mission to ensure excellence in clinical research.
To keep up with growth, many companies are turning to contract manufacturing organizations (CMOs) to assist with product manufacturing. A key benefit CMOs provide is to maintain a manufacturing footprint, and the skilled talent needed to support product manufacturing.
Artificial intelligence (AI) is transforming healthcare, promising improved patient outcomes, streamlined drug development, and enhanced diagnostics. Beyond its most immediately recognized advancements, AI is revolutionizing clinical trials and medical device development—areas that clinical research professionals may not yet fully appreciate.
You’ve probably heard it all before: The clinical research enterprise has a problem with expecting new hires in what are often basically low-paying, entry-level positions to already have two or more years of experience with the position’s duties. It’s a talent acquisition model that does no one any favors, especially at the study site level where a healthy pipeline of new clinical research coordinators (CRCs) would go a long way to alleviating delays in trial conduct.